Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 6:9:1082604.
doi: 10.3389/fmed.2022.1082604. eCollection 2022.

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis

Anne Bull Haaversen  1 , Lene Kristin Brekke  2 , Gunnstein Bakland  3 , Erik Rødevand  4 , Geirmund Myklebust  5 , Andreas P Diamantopoulos  6
Affiliations

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis

Anne Bull Haaversen et al. Front Med (Lausanne). .

Abstract

Objective: To provide clinical guidance to Norwegian Rheumatologists and other clinicians involved in diagnosing and treating patients with giant cell arteritis (GCA).

Methods: The available evidence in the field was reviewed, and the GCA working group wrote draft guidelines. These guidelines were discussed and revised according to standard procedures within the Norwegian Society of Rheumatology. The European Alliance of Associations for Rheumatology (EULAR) recommendations for imaging and treatment in large vessel vasculitis and the British Society for Rheumatology (BSR) guidelines for diagnostics and treatment in GCA informed the development of the current guidelines.

Results: A total of 13 recommendations were developed. Ultrasound is recommended as the primary diagnostic test. In patients with suspected GCA, treatment with high doses of Prednisolone (40-60 mg) should be initiated immediately. For patients with refractory disease or relapse, Methotrexate (MTX) should be used as the first-line adjunctive therapy, followed by tocilizumab (TCZ).

Conclusion: Norwegian recommendations for diagnostics and treatment to improve management and outcome in patients with GCA were developed.

Keywords: diagnosis; giant cell arteritis (GCA); guidelines; large vessel vasculitis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Diagnostic algorithm for giant cell arteritis (GCA).
FIGURE 2
FIGURE 2
Treatment algorithm for giant cell arteritis (GCA).
See this image and copyright information in PMC

References

    1. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. (2003) 349:160–9. - PubMed
    1. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. (2017) 56:506–15. 10.1093/rheumatology/kew273 - DOI - PubMed
    1. Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. (2014) 371:50–7. - PMC - PubMed
    1. Schmidt J, Warrington KJ. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs Aging. (2011) 28:651–66. - PubMed
    1. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum. (2004) 33:294–301. - PubMed

Publication types

LinkOut - more resources